Sort by
Keyphrases
Complete Metabolic Response
80%
Concurrent Chemoradiotherapy
20%
Fluorodeoxyglucose Positron Emission Tomography/computed Tomography
20%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
100%
Hypopharyngeal
20%
Long Progression-free Survival
20%
Metabolic Disease
100%
Metabolic Response
80%
Nasopharyngeal
20%
Oropharyngeal
20%
Overall Survival
40%
PET Response Criteria in Solid Tumors
100%
Prediction of Death
20%
Prognosis Prediction
100%
Progression-free Survival
20%
Recurrence Prediction
40%
Recurrent Disease
20%
Response to Chemoradiotherapy
100%
Therapeutic Response
40%
Tumor Response
100%
Medicine and Dentistry
Chemoradiotherapy
100%
Fluorodeoxyglucose
20%
Head and Neck Squamous Cell Carcinoma
100%
Malignant Neoplasm
20%
Neoplasm
100%
Overall Survival
40%
positron emission tomographic scan
100%
Positron Emission Tomography-Computed Tomography
20%
Progression Free Survival
40%
Recurrent Disease
100%
Solid Malignant Neoplasm
100%
Treatment Response
40%
Water-Electrolyte Imbalance
100%
Pharmacology, Toxicology and Pharmaceutical Science
Chemoradiation Therapy
100%
Fluorodeoxyglucose
20%
Head and Neck Squamous Cell Carcinoma
100%
Malignant Neoplasm
20%
Metabolic Disorder
100%
Neoplasm
100%
Overall Survival
40%
Progression Free Survival
40%
Recurrent Disease
100%
Solid Malignant Neoplasm
100%
Immunology and Microbiology
Neck
100%
Overall Survival
40%
positron emission tomographic scan
100%
Positron Emission Tomography-Computed Tomography
20%
Progression Free Survival
40%
Squamous Cell
100%